177Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer: Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial
2025 · International Journal of Radiation Oncology*Biology*Physics · 1 citations
https://doi.org/10.1016/j.ijrobp.2025.06.1008